Switching associated with initiation of calcitonin gene-related peptide monoclonal antibodies versus non-calcitonin gene-related peptide monoclonal antibodies treatments for prevention of migraine

被引：0
|
作者：
Foster, S. A. [1 ]
Manjelievskaia, J. [2 ]
Ford, J. H. [1 ]
Ye, W. [3 ]
Perry, A. [4 ]
Schuh, K. [1 ]
Wenzel, R. [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] IBM Watson Hlth, Armonk, NY USA
[3] Eli Lilly & Co, Indianapolis, IN 46285 USA
[4] IBM Watson Hlth, Roslyn Hts, NY USA
来源：
HEADACHE | 2021年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-87
引用
收藏
页码：75 / 76
页数：2
相关论文
共 50 条
  • [1] Adherence and persistence associated with calcitonin gene-related peptide monoclonal antibodies compared to non-calcitonin gene-related peptide monoclonal antibodies treatments for prevention of migraine
    Foster, S. A.
    Manjelievskaia, J.
    Ford, J. H.
    Ye, W.
    Perry, A.
    Schuh, K.
    Wenzel, R.
    HEADACHE, 2021, 61 : 54 - 54
  • [2] Calcitonin gene-related peptide (CGRP) monoclonal antibodies for migraine
    Giffin, Nicola J.
    PRACTICAL NEUROLOGY, 2023, 23 (03) : 200 - +
  • [3] Switching Associated with Initiation of Calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibodies (mAbs) Versus non-CGRP mAb Treatments for Prevention of Migraine
    Foster, S. A.
    Manjelievskaia, J.
    Ford, J. H.
    Ye, W.
    Perry, A.
    Schuh, K.
    Wenzel, R.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 74 - 74
  • [4] Switching Associated with Initiation of Calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibodies (mAbs) Versus non-CGRP mAb Treatments for Prevention of Migraine
    Foster, S. A.
    Manjelievskaia, J.
    Ford, J. H.
    Ye, W.
    Perry, A.
    Schuh, K.
    Wenzel, R.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 48 - 48
  • [5] Monoclonal Antibodies for Migraine: Preventing Calcitonin Gene-Related Peptide Activity
    Marcelo E. Bigal
    Sarah Walter
    CNS Drugs, 2014, 28 : 389 - 399
  • [6] Monoclonal Antibodies for Migraine: Preventing Calcitonin Gene-Related Peptide Activity
    Bigal, Marcelo E.
    Walter, Sarah
    CNS DRUGS, 2014, 28 (05) : 389 - 399
  • [7] Calcitonin Gene-Related Peptide Monoclonal Antibody Treatments for Migraine
    Loder, Elizabeth
    Renthal, William
    JAMA INTERNAL MEDICINE, 2019, 179 (03) : 421 - 422
  • [8] Monoclonal antibodies against calcitonin gene-related peptide for the prophylaxis of migraine with aura
    Kim, B. K.
    Lee, H. C.
    Cho, S.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [9] Use of Anti-calcitonin Gene-Related Peptide Monoclonal Antibodies in Pediatric Migraine Prevention
    Suleman, Saher
    Chow, Clara
    Rastogi, Reena Gogia
    NEUROLOGY, 2021, 96 (15)
  • [10] The Biology of Monoclonal Antibodies: Focus on Calcitonin Gene-Related Peptide for Prophylactic Migraine Therapy
    Bianca Raffaelli
    Uwe Reuter
    Neurotherapeutics, 2018, 15 : 324 - 335
12345